World's Best Scientists 2026 revealed!
Award Badge
Best Female Scientists
2025

D-Index & Metrics

Best Female Scientists

D-Index
126
Citations
60379
World Ranking
419
National Ranking
252

Medicine

D-Index
127
Citations
63268
World Ranking
2817
National Ranking
1569

Research.com Recognitions

  • 2025 - Research.com Best Female Scientists Award

Overview

Alice B. Gottlieb is affiliated with the Icahn School of Medicine at Mount Sinai in the United States. Their research primarily focuses on the fields of Medicine and Immunology and Microbiology, with a significant number of publications in Immunology, Rheumatology, Dermatology, Hematology, and Economics and Econometrics.

Their work covers several main topics, including:

  • Psoriasis: Treatment and Pathogenesis
  • Spondyloarthritis Studies and Treatments
  • Autoimmune and Inflammatory Disorders Research
  • Dermatology and Skin Diseases
  • Health Systems, Economic Evaluations, Quality of Life
  • Rheumatoid Arthritis Research and Therapies
  • Autoimmune Bullous Skin Diseases

They have published extensively in several journals, notably:

  • Journal of the American Academy of Dermatology
  • SKIN The Journal of Cutaneous Medicine
  • Annals of the Rheumatic Diseases
  • Dermatology and Therapy
  • The Journal of Rheumatology

Among their recent research papers are:

  • Guselkumab in biologic-naive patients with active psoriatic arthritis (DISCOVER-2): a double-blind, randomised, placebo-controlled phase 3 trial (2020, The Lancet)
  • Joint American Academy of Dermatology-National Psoriasis Foundation guidelines of care for the management of psoriasis with systemic nonbiologic therapies (2020, Journal of the American Academy of Dermatology)
  • Joint AAD-NPF Guidelines of care for the management and treatment of psoriasis with topical therapy and alternative medicine modalities for psoriasis severity measures (2020, Journal of the American Academy of Dermatology)
  • Secukinumab versus adalimumab for treatment of active psoriatic arthritis (EXCEED): a double-blind, parallel-group, randomised, active-controlled, phase 3b trial (2020, The Lancet)
  • Secukinumab in moderate-to-severe hidradenitis suppurativa (SUNSHINE and SUNRISE): week 16 and week 52 results of two identical, multicentre, randomised, placebo-controlled, double-blind phase 3 trials (2023, The Lancet)

Frequent co-authors in their work include:

  • Joseph F. Merola
  • Mark Lebwohl
  • Philip J. Mease
  • April W. Armstrong
  • Richard B. Warren

Best Publications

  • Guidelines of care for the management of psoriasis and psoriatic arthritis: Section 1. Overview of psoriasis and guidelines of care for the treatment of psoriasis with biologics

    Alan Menter;Alice Gottlieb;Steven R. Feldman;Abby S. Van Voorhees

  • Etanercept as monotherapy in patients with psoriasis

    Craig L. Leonardi;Jerold L. Powers;Robert T. Matheson;Bernard S. Goffe

  • Etanercept and clinical outcomes, fatigue, and depression in psoriasis: double-blind placebo-controlled randomised phase III trial

    Stephen Tyring;Alice Gottlieb;Kim Papp;Ken Gordon

  • Efficacy and safety of infliximab monotherapy for plaque-type psoriasis: a randomised trial

    U Chaudhari;P Romano;LD Mulcahy;LT Dooley

  • Guidelines of care for the management of psoriasis and psoriatic arthritis: Section 2. Psoriatic arthritis: Overview and guidelines of care for treatment with an emphasis on the biologics

    Alice Gottlieb;Neil J. Korman;Kenneth B. Gordon;Steven R. Feldman

  • Interleukin 6 is expressed in high levels in psoriatic skin and stimulates proliferation of cultured human keratinocytes.

    Rachel M. Grossman;James Krueger;Debra Yourish;Angela Granelli-Piperno

  • Group for Research and Assessment of Psoriasis and Psoriatic Arthritis 2015 Treatment Recommendations for Psoriatic Arthritis

    Laura C. Coates;Arthur Kavanaugh;Philip J. Mease;Enrique R. Soriano

  • Secukinumab, a human anti-interleukin-17A monoclonal antibody, in patients with psoriatic arthritis (FUTURE 2) : a randomised, double-blind, placebo-controlled, phase 3 trial

    Iain B McInnes;Philip J Mease;Bruce Kirkham;Arthur Kavanaugh

  • Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with biologics.

    Alan Menter;Bruce E. Strober;Daniel H. Kaplan;Dario Kivelevitch

  • Efficacy and safety of ustekinumab in patients with active psoriatic arthritis: 1 year results of the phase 3, multicentre, double-blind, placebo-controlled PSUMMIT 1 trial

    Iain B McInnes;Arthur Kavanaugh;Alice B Gottlieb;Lluís Puig

  • Efficacy and safety of the anti-IL-12/23 p40 monoclonal antibody, ustekinumab, in patients with active psoriatic arthritis despite conventional non-biological and biological anti-tumour necrosis factor therapy: 6-month and 1-year results of the phase 3, multicentre, double-blind, placebo-controlled, randomised PSUMMIT 2 trial

    Christopher Ritchlin;Proton Rahman;Arthur Kavanaugh;Iain B McInnes

  • Ustekinumab, a human interleukin 12/23 monoclonal antibody, for psoriatic arthritis: randomised, double-blind, placebo-controlled, crossover trial

    Alice Gottlieb;Alan Menter;Alan Mendelsohn;Yaung-Kaung Shen

  • Infliximab induction therapy for patients with severe plaque-type psoriasis: A randomized, double-blind, placebo-controlled trial

    Alice B. Gottlieb;Robert Evans;Shu Li;Lisa T. Dooley

  • Two Phase 3 Trials of Adalimumab for Hidradenitis Suppurativa.

    Alexa B Kimball;Martin M Okun;David A Williams;Alice B Gottlieb

  • Response of psoriasis to a lymphocyte-selective toxin (DAB389IL-2) suggests a primary immune, but not keratinocyte, pathogenic basis.

    Scott L. Gottlieb;Patricia Gilleaudeau;Ray Johnson;Len Estes

  • Treatment recommendations for psoriatic arthritis

    C. T. Ritchlin;A. Kavanaugh;D. D. Gladman;P. J. Mease

  • Guidelines of Care for the Management of Psoriasis and Psoriatic Arthritis. Section 3. Guidelines of Care for the Management and Treatment of Psoriasis With Topical Therapies

    Alan Menter;Neil J. Korman;Craig A. Elmets;Steven R. Feldman

  • Guidelines of care for the management of psoriasis and psoriatic arthritis: section 4. Guidelines of care for the management and treatment of psoriasis with traditional systemic agents.

    Alan Menter;Neil J. Korman;Craig A. Elmets;Steven R. Feldman

  • A randomized comparison of continuous vs. intermittent infliximab maintenance regimens over 1 year in the treatment of moderate-to-severe plaque psoriasis

    Alan Menter;Steven R. Feldman;Gerald D. Weinstein;Kim Papp

  • A Randomized Trial of Etanercept as Monotherapy for Psoriasis

    Alice B. Gottlieb;Robert T. Matheson;Nicholas Lowe;Gerald G. Krueger

Frequent Co-Authors

Mark Lebwohl
Mark Lebwohl Icahn School of Medicine at Mount Sinai
Philip J. Mease
Philip J. Mease University of Washington
Kenneth B. Gordon
Kenneth B. Gordon Medical College of Wisconsin
James G. Krueger
James G. Krueger Rockefeller University
Alan Menter
Alan Menter Texas A&M University
Craig L. Leonardi
Craig L. Leonardi Saint Louis University
Christopher T. Ritchlin
Christopher T. Ritchlin University of Rochester Medical Center
Arthur Kavanaugh
Arthur Kavanaugh University of California, San Diego
Kim Papp
Kim Papp Probity Medical Research
Dafna D. Gladman
Dafna D. Gladman Toronto Western Hospital

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring online degrees can open up rewarding career pathways beyond traditional medical school. One fast-growing field is healthcare administration. An online master of health administration offers flexibility for those who wish to lead and manage medical organizations without the time commitment of earning an MD.

Prospective students should consider financial factors when pursuing a graduate credential. The cost of mha degree programs can vary widely, but there are affordable options to suit various budgets, especially online.

Advanced nursing degrees are also in high demand. For nurses aiming to become leaders in healthcare practice and policy, the cheapest online dnp programs provide accessible pathways to a Doctor of Nursing Practice qualification.

Another related career route is pharmacy. Online education now makes it possible to pursue pharmd online programs, preparing graduates for pharmacy licensure and practice in a flexible format.

Whether you’re interested in administration, advanced nursing, or pharmacy, online degrees combine flexibility, affordability, and strong career prospects in the evolving health sector.

Best Scientists Citing Alice B. Gottlieb

Trending Scientists

Recently Published Articles